Neutrophil to Lymphocyte Ratio after Treatment Completion as a Potential Predictor of Survival in Patients with Triple-Negative Breast Cancer

PURPOSE: Triple-negative breast cancer (TNBC) has been associated with worse prognosis, and biomarkers are needed to identify high-risk patients who may benefit from clinical trials or escalated treatment after completion of standard treatment. We aimed to assess whether the post-treatment neutrophi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Kwang-Min, Choi, Hyang Suk, Noh, Hany, Cho, In-Jeong, Lim, Seung Taek, Lee, Jong-In, Han, Airi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Breast Cancer Society 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8561138/
https://www.ncbi.nlm.nih.gov/pubmed/34652080
http://dx.doi.org/10.4048/jbc.2021.24.e43

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8561138/
https://www.ncbi.nlm.nih.gov/pubmed/34652080
http://dx.doi.org/10.4048/jbc.2021.24.e43

Ejemplares similares